What is a Good Annual Rate of Return?
Understand how to evaluate investment returns, discount rates, and what realistic expectations look like for long-term value investing.
Should you buy Regeneron Pharmaceuticals stock? (NasdaqGS:REGN). Let's see how it does in our automated value investing analysis system.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold Regeneron Pharmaceuticals to reach your target.
| Advantages | Disadvantages | Neutral |
|---|---|---|
| None. |
|
|
| REGN Price (Regeneron Pharmaceuticals stock price per share) |
$583.64 | |
|
|
REGN Fair Price (based on intrinsic value) |
$133.50 |
| REGN Safety Price (based on a variable margin of safety) | $80.10 | |
| PE Ratio versus Sector | 18% lower than other Unknown stocks | |
| PE Ratio versus Industry | 71% lower than other Unknown stocks | |
| Cash Yield | 0.74% | |
| Free Cash Flow Jitter | 48% |
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 1,920,008 shares shorted. With 98,649,827 shares available for purchase and an average trading volume over the past 10 trading days of 1,045,600, it would take at least 1.836 days for all of the short holders to cover their shorts.
Understand how to evaluate investment returns, discount rates, and what realistic expectations look like for long-term value investing.
Learn when dividend yields signal opportunity versus risk, and how to evaluate dividend sustainability in your portfolio.
Master the methods for projecting company growth rates and earnings, essential for calculating intrinsic value with confidence.
We believe that Regeneron Pharmaceuticals may be worth examining further. It's making money, which is a very positive sign. Is it on sale?
Regeneron Pharmaceuticals looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.
Advertisement supports free stock analysis content.
Does Regeneron Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to REGN: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.
Most Popular Articles
What is the myRA Retirement Savings Account?
Comparing Debt to Assets for Stocks